Dectin-2 Is a Direct Receptor for Mannose-Capped Lipoarabinomannan of Mycobacteria  by Yonekawa, Akiko et al.
Immunity
ArticleDectin-2 Is a Direct Receptor for Mannose-Capped
Lipoarabinomannan of Mycobacteria
Akiko Yonekawa,1,2,9 Shinobu Saijo,3,4,9 Yoshihiko Hoshino,5 Yasunobu Miyake,1 Eri Ishikawa,1 Maho Suzukawa,6
Hiromasa Inoue,7 Masato Tanaka,8 Mitsutoshi Yoneyama,3 Masatsugu Oh-hora,1,4 Koichi Akashi,2 and Sho Yamasaki1,3,*
1Division of Molecular Immunology, Medical Institute of Bioregulation
2Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences
Kyushu University, Fukuoka 812-8582, Japan
3Division of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan
4PRESTO, Japan Science and Technology Agency (JST), Saitama 332-0012, Japan
5Leprosy Research Center, National Institute of Infectious Diseases, Tokyo 189-0002, Japan
6Center for Pulmonary Diseases, National Hospital Organization, Tokyo National Hospital, Tokyo 204-8585, Japan
7Department of Pulmonary Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan
8Laboratory for Immune Regulation, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan
9Co-first author
*Correspondence: yamasaki@bioreg.kyushu-u.ac.jp
http://dx.doi.org/10.1016/j.immuni.2014.08.005SUMMARY
Mycobacteria possess various immunomodulatory
molecules on the cell wall. Mannose-capped lipoara-
binomannan (Man-LAM), amajor lipoglycan ofMyco-
bacterium tuberculosis, has long been known to
have both inhibitory and stimulatory effects on host
immunity. However, the direct Man-LAM receptor
that explains its pleiotropic activities has not been
clearly identified. Here, we report that a C-type lectin
receptor Dectin-2 (gene symbol Clec4n) is a direct
receptor for Man-LAM. Man-LAM activated bone-
marrow-derived dendritic cells (BMDCs) to produce
pro- and anti-inflammatory cytokines, whereas it
was completely abrogated in Clec4n–/– BMDCs.
Man-LAM promoted antigen-specific T cell re-
sponses through Dectin-2 on DCs. Furthermore,
Man-LAM induced experimental autoimmune en-
cephalitis (EAE) as an adjuvant in mice, whereas
Clec4n–/– mice were resistant. Upon mycobacterial
infection, Clec4n–/– mice showed augmented lung
pathology. These results demonstrate that Dectin-2
contributes to host immunity against mycobacterial
infection through the recognition of Man-LAM.
INTRODUCTION
Mycobacteria possess various cell wall components that influ-
ence host immune responses, such as trehalose-6,60-dimyco-
late (TDM), mycolate, phosphatidyl-myo-inositol mannosides
(PIMs), lipomannnan (LM), and lipoarabinomannan (LAM). LAM
is a major lipoglycan and important virulence factor of mycobac-
teria (Mishra et al., 2011), enabling mycobacteria to infect host
organisms and survive within host cells. Ethambutol, an inhibitor
of LAM synthesis, is widely used as an antimycobacterial drug
(Belanger et al., 1996). LAM consists of four components: aman-402 Immunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc.nosyl-phosphatidyl-myo-inositol (MPI) anchor, amannose back-
bone, an arabinan domain, and capping moieties. The capping
moieties located at the terminal extremity of the arabinan domain
differ among mycobacterial species, such as mannose-capped
LAM (Man-LAM), phosphoinositol-capped LAM (PI-LAM), and
noncapped LAM (Ara-LAM). Among them, Man-LAM has been
intensively studied because it exerts pleiotropic effects on host
immunity (Mishra et al., 2011).
Pathogenic species, including Mycobacterium tuberculosis,
possess Man-LAM, which has been shown to suppress host im-
mune system (Briken et al., 2004) and phagosome-lysosome
fusion (Fratti et al., 2003). Although various inhibitory mecha-
nisms have been proposed thus far, one of the key events is
the production of immunosuppressive cytokine interleukin-10
(IL-10). On the other hand, Man-LAM also potentiates immunos-
timulatory responses, such as nitric oxide release and secretion
of proinflammatory cytokines (Chan et al., 2001; Gringhuis et al.,
2009; Mazurek et al., 2012).
C-type lectin receptors (CLRs) have been recently identified as
pattern recognition receptors (PRRs) for a wide variety of patho-
gens. A member of CLRs, dendritic-cell (DC)-specific intercel-
lular adhesion molecule-3 grabbing nonintegrin (DC-SIGN, also
called CD209) and its putative murine homologs SIGN-related
1 (SIGNR1, also called CD209b) and SIGNR3 (CD209d) are re-
ported to recognize Man-LAM and mediate its immunosuppres-
sive activities (Geijtenbeek et al., 2003; Schlesinger et al., 1994;
Tailleux et al., 2003). Macrophagemannose receptor (MMR, also
called CD206) is also a candidate for inhibitory receptor for LAM,
because it delivers a negative signal to attenuate DC activation
(Nigou et al., 2001). In addition to these reports regarding inhib-
itory functions, engagement of SIGNR3 by Man-LAM also in-
duces the secretion of IL-6 and tumor necrosis factor (TNF) in
macrophages transfected with SIGNR3 (Tanne et al., 2009).
Moreover, the scavenger receptor CD36 enhances the stimula-
tory activity of Man-LAM leading to TNF release in lipopolysac-
charide (LPS)-stimulated macrophage cell line (Jo´zefowski
et al., 2011). Although many proteins have been proposed as a
receptor for Man-LAM, none of these receptors fully explain its
divergent functions, both stimulatory and inhibitory effects,
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Figure 1. LAM Induces EAE through FcRg Axis
(A and B) WT (n = 4) and Fcer1g–/– (n = 4) mice were immunized with MOG35-55
peptide in IFA containing LAM (500 mg), followed by i.p. injection of PT
(500 ng) (day 1, 2, and 3). The disease severity of each mouse was scored, and
mean clinical score (A) and disease incidence (B) at the indicated times were
plotted.
(C and D) Lumbar (C) and inguinal (D) lymph nodes were collected at 23 days
after immunization. Lymph node cells were stimulated with MOG35-55 peptide
for 4 days. Concentrations of IL-17, IFN-g, and GM-CSF were determined with
ELISA.
(E and F) BMDCs obtained from WT, Clec4e–/–, Fcer1g–/–, or MyD88–/– mice
were stimulated with plate-coated LAM (0.3 mg/well) or LPS (10 ng/ml) for
48 hr. The concentrations of MIP-2 (E) and TNF (F) were measured using
ELISA.
(A–D) Data are representative of two separate experiments.
(E and F) All data are presented as the means ± SD of triplicate and are
representative of three separate experiments.
See also Figure S1.
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Imsuggesting the possibility that unidentified molecules act as re-
ceptors for Man-LAM.
We recently demonstrated that CLRs Mincle (gene symbol
Clec4e) and MCL (gene symbol Clec4d) are Fc receptor g chain
(FcRg, gene symbol Fcer1g)-coupled activating receptors for
mycobacterial glycolipids (Ishikawa et al., 2009; Miyake et al.,
2013). Another CLR, DC-associated C-type lectin-2 (Dectin-2,
gene symbol Clec4n), is located adjacent to Mincle and MCL
within the gene cluster on chromosome 6. Dectin-2 is an
FcRg-coupled CLR (Sato et al., 2006) that recognizes Candida
albicans hyphae to mediate host defense against the fungus
(Robinson et al., 2009; Saijo et al., 2010). Dectin-2 and MCL
seem to have arisen by gene duplication from Mincle after pla-
centalia and are well conserved among species (Miyake et al.,
2013). These findings imply that theseCLRswithin the gene clus-
ter might have evolved as ‘‘mycobacterial receptors’’ and that
Dectin-2 might also recognize mycobacteria.
In this study, we show that Dectin-2 is a direct receptor for
Man-LAM. Man-LAM recognition by Dectin-2 induced the
production of both pro- and anti-inflammatory cytokines in
DCs. Man-LAM potently promoted T-cell-mediated acquired
immunity as an adjuvant without causing detrimental inflamma-
tion. We further demonstrate, through Dectin-2-deficient mice,
that Dectin-2 plays a critical role in host responses against
mycobacterial infection. Collectively, these findings indicate
that Dectin-2 acts as a functional PRR for mycobacterial
Man-LAM.
RESULTS
LAM Promotes Experimental Autoimmune
Encephalomyelitis through FcRg
We first investigated whether LAM possess adjuvant activity
in vivo. To this end, we performed amurinemodel of T-cell-medi-
ated autoimmune disease, experimental autoimmune ence-
phalomyelitis (EAE) (Figures 1A–1D). Mice were immunized
with myelin oligodendrocyte glycoprotein (MOG) peptide to-
gether with LAM derived from virulent M. tuberculosis strain
Aoyama B. Although EAE was not induced by incomplete
Freund’s adjuvant (IFA) alone (data not shown), a single injection
of LAM elicited EAE with 100% incidence (Figures 1A and 1B).
The EAE symptoms were completely abrogated in Fcer1g–/–
mice (Figures 1A and 1B), suggesting that FcRg-coupled recep-
tor(s) might contribute to LAM-induced EAE. Furthermore, in
contrast to lymphocytes from wild-type mice, lymphocytes
from Fcer1g–/– mice exhibited impaired ex vivo recall responses
to MOG peptides as judged by the production of IL-17, inter-
feron-g (IFN-g), and granulocyte macrophage-colony stimu-
lating factor (GM-CSF) (Figures 1C and 1D). These results
indicate that LAM could act as a potent adjuvant leading to the
development of EAE through an FcRg-dependent pathway.
Because FcRg is mainly expressed in myeloid cells, we next
treated DCs with LAM in vitro. To recapitulate uniform configura-
tion and multivalency of LAM on the bacterial wall, LAM was
coated on culture plate for the stimulation of bone-marrow-
derived DCs (BMDCs). Although soluble LAM did not induce
cytokine production (data not shown), plate-coated LAM could
stimulate BMDCs to secrete a large amount of the proinflamma-
tory cytokines, macrophage inflammatory protein-2 (MIP-2), andmunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc. 403
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Figure 2. Dectin-2 Recognizes Pathogenic
Mycobacterial Species though LAM
(A) NFAT-GFP reporter cells expressing Mincle +
FcRg (Mincle) or Dectin-2 + FcRg (Dectin-2) were
stimulated with heat-killed M. tuberculosis H37Rv
or M. bovis BCG. TDM and Candida albicans cell
wall mannan were used in plate-coated form as a
positive control.
(B) Reporter cells were stimulated with plate-
coated water extract or C:M extract for 24 hr.
(C) Reporter cells expressing FcRg alone or Dec-
tin-2 + FcRg were stimulated with the indicated
amounts of LAM derived from M. tuberculosis
strain Aoyama B in plate-coated form for 24 hr.
Induction of NFAT-GFP was analyzed using flow
cytometry. All data are presented as the means ±
SD of triplicate assays and representative results
from three independent experiments with similar
results are shown. See also Figure S2.
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Dectin-2 Is a Receptor for Mycobacterial Man-LAMTNF (Figures 1E and 1F). These cytokines were still produced in
Clec4e–/– (Figures 1E and 1F) and Clec4d–/– (data not shown)
DCs. MyD88 was dispensable for this response, indicating
that toll-like receptors (TLRs) do not play major role in LAM
recognition. In contrast, LAM-induced cytokine production was
abrogated in Fcer1g–/– DCs. These results suggest that some un-
known FcRg-coupled receptor(s) might function as an activating
receptor for LAM in BMDCs.
Dectin-2 Recognizes Mycobacterial LAM
Mincle, MCL, and Dectin-2 are FcRg-coupled activating recep-
tors within the same gene cluster, and two of these receptors,
Mincle and MCL, recognize mycobacteria (Ishikawa et al.,
2009; Miyake et al., 2013). We therefore assumed that Dectin-
2 might also be evolved as a receptor for mycobacteria. Indeed,
Dectin-2 was demonstrated to recognize the virulent strain
M. tuberculosis H37Rv and the vaccine strain M. bovis Bacille
de Calmette et Gue´rin (BCG) to activate the reporter cells, in a
similar manner to Mincle (Figure 2A). However, the ligand for
Dectin-2 was distinct from Mincle ligand trehalose-6,60-dimyco-
late (TDM) (Figure 2A).
We next fractionated components ofM. bovis BCG using lipo-
philic and hydrophilic solvents, such as chloroform:methanol
(C:M) and water. The Dectin-2 ligand activity for each of the ex-
tracts was assessed in a plate-coated form using reporter cells.
We found that only the water phase demonstrated a stimulatory
activity for Dectin-2 (Figure 2B, right), in sharp contrast to the
C:M phase that activates Mincle-expressing cells (Figure 2B,
left) (Ishikawa et al., 2009). These results suggest that the hydro-
philic components of mycobacteria are candidates for the Dec-
tin-2 ligand. Among mycobacterial hydrophilic components,
LAM constitutes the most abundant hydrophilic lipoglycan (Fig-
ure S1 available online; Leopold and Fischer, 1993). In agree-
ment with our prediction, LAM derived from M. tuberculosis404 Immunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc.activated reporter cells expressing Dec-
tin-2 (Figure 2C). Dectin-2 directly recog-
nized the LAM, as shown by the fact that
soluble Dectin-2 protein (Dectin-2-Ig)
bound to purified LAM in a dose-depen-dent manner (Figure S2). These findings indicate that Dectin-2
is a direct receptor for mycobacterial LAM.
Dectin-2 Recognizes Mycobacteria through
Mannose-Capped LAM
The structure of LAM differs depending on the mycobacterial
species, particularly with the respect to the capping moieties
(Briken et al., 2004). The slow-growing strains including
M. tuberculosis and M. bovis BCG possess Man-LAM, whereas
rapid-growing strains of mycobacteria do not. M. smegmatis
possesses PI-LAM. To clarify which structure of LAM is res-
ponsible for the interaction with Dectin-2, we used various
strains of mycobacteria including nontuberculosis mycobacte-
ria (NTM).
Dectin-2 recognized slow-growing strains, such as
M. intracellulare and M. gordonae, which possess Man-LAM.
In contrast, Dectin-2 did not recognize M. abscessus and
M. smegmatis that lack mannose capping (Figure 3A). Impor-
tantly, Mincle was capable of recognizing these strains (Fig-
ure 3A). We confirmed that none of these strains activated
reporter cells expressing FcRg alone (data not shown). These re-
sults suggest that Dectin-2 preferentially recognizes the myco-
bacterial species that expressMan-LAM. Supporting this notion,
the activity of Man-LAM derived fromM. tuberculosis (Figure 2C)
was abolished by treatment with a-mannosidase that removes
terminal mannose caps (Figure 3B). These results indicate that
the capping structures are crucial determinants for the recogni-
tion of Man-LAM by Dectin-2.
We next investigated whether the mannose binding capacity
of Dectin-2 is involved in Man-LAM recognition. To this end,
we employed the Dectin-2QPD mutant in which the mannose-
binding activity was eliminated by substituting EPN (gluta-
mic acid-proline-asparagine) sequence into galactose-type
QPD (glutamine-proline-asparagic acid) sequence (Drickamer,
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Figure 3. Dectin-2 Selectively Recognizes
Mannose-Capped LAM
(A) NFAT-GFP reporter cells expressing Mincle +
FcRg or Dectin-2 + FcRg were stimulated with the
indicated strains of heat-killed NTM.
(B) Reporter cells expressing Dectin-2 + FcRg
were stimulated withM. bovisBCGpretreatedwith
or without a-mannosidase for 24 hr.
(C and D) Reporter cells expressing Dectin-2WT +
FcRg or Dectin-2QPD + FcRg were stimulated with
plate-coated LAM (C) and NTM strains (D) for
24 hr.
All data are presented as the means ± SD of trip-
licate and are representative of three separate
experiments. See also Figure S3.
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cells expressing Dectin-2QPD (Figure 3C) regardless of similar
fluorescence intensities of wild-type Dectin-2 and Dectin-
2QPD on the cell surface (Figure S3). The recognition of whole
mycobacteria by Dectin-2 was also dependent on this EPN
motif (Figure 3D). Collectively, these results indicate that both
mannose caps of Man-LAM and mannose-recognition property
of Dectin-2 are required for the interaction of Man-LAM with
Dectin-2.
Man-LAM Induces Cytokine Production by DCs in a
Dectin-2-Dependent Manner
Among the myeloid cells, DCs most abundantly express Dectin-
2 (Ariizumi et al., 2000). We therefore investigated the cytokine
production in response to Man-LAM in BMDCs. Man-LAM,
similar to TDM, induced the expression of inflammatory cyto-
kines, such as MIP-2, TNF, and IL-6, in a dose-dependent
manner (Figure 4A). The LAM-induced cytokine production
was abolished in Clec4n/ BMDCs, whereas the TDM-medi-
ated cytokine production was not altered (Figure 4A). Man-Immunity 41, 402–413, SeLAM also slightly enhanced IL-12p40 in
a Dectin-2-dependent manner (data not
shown). The production of TNF and IL-6
uponM. bovis BCG infection was partially
decreased in Clec4n/ BMDCs as com-
paredwithWTBMDCs, although there re-
mained Dectin-2-independent cytokine
production (Figure 4B). These data indi-
cate that Dectin-2 is critical for Man-
LAM-mediated proinflammatory cytokine
production in DCs.
We next focused on the anti-inflam-
matory potential of Man-LAM-Dectin-2
pathway, due to the fact that accumu-
lating evidence has emphasized the
importance of the immune-suppressive
action of Man-LAM (Geijtenbeek et al.,
2003; Wieland et al., 2007). In addition
to proinflammatory cytokines, Man-LAM
potently induced the production of anti-
inflammatory cytokine, IL-10, in BMDCs
(Figure 4C, left). Other pathogen-associ-
ated molecular patterns (PAMPs), TDM(Figure 4C, right) and LPS (data not shown), did not induce
the secretion of IL-10 and IL-2, indicating that Man-LAM has
a unique profile of the cytokine production. Man-LAM-induced
release of these cytokines was completely suppressed in
Clec4n/ BMDCs (Figure 4C). Although TNF production during
M. bovis BCG infection was partially dependent on Dectin-2 as
described above (Figure 4B), the production of IL-10 and IL-2
was almost completely lost in Clec4n/ DCs infected with
M. bovis BCG (Figure 4D). Meanwhile, M. abscessus, which
is absent from mannose caps, failed to induce the production
of IL-10 and IL-2, compared to the capability of MIP-2 pro-
duction (Figure 4E). These results suggest a central role of
Dectin-2 in the production of IL-10 and IL-2 in response to
mycobacteria.
Dectin-2-Mediated Intrinsic Signal Regulates
Man-LAM-Induced Cytokine Production in DCs
It is clear that Dectin-2 is required for the cytokine production
induced by Man-LAM, because such production is abrogated
in Clec4n/ cells (Figures 4A and 4C). However, it is stillptember 18, 2014 ª2014 Elsevier Inc. 405
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Figure 4. LAM Induces Cytokine Production
in a Dectin-2-Dependent Manner
(A–D) BMDCs obtained fromWT or Clec4n–/– mice
were stimulated with the indicated amounts of
plate-coated LAM or TDM for 48 hr (A and C).
BMDCs were infected with 1 to 10 3 109 of
M. bovis BCG for 48 hr (B and D). LPS was used as
control. The concentrations of MIP-2, TNF, IL-6 (A
and B), IL-10, and IL-2 (C and D) were measured
using ELISA.
(E) BMDCs were stimulated for 48 hr withM. bovis
BCG or clinical isolates of heat-killed
M. abscessus derived from ten individual patients.
The concentrations of MIP-2, IL-10, and IL-2 were
measured using ELISA.
All data are presented as the means ± SD of trip-
licate and are representative of three separate
experiments. See also Figure S4.
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cient or whether some other coreceptor is also required for these
responses. The unique cytokine profiles, particularly IL-10 and
IL-2 production, may be conferred by the coengagement of Dec-
tin-2 and other Man-LAM receptors. To examine this possibility,
we investigated the contribution of several candidate receptors
for Man-LAM. Since SIGNR1, a putative murine homolog of hu-
man DC-SIGN, recognizes Man-LAM (Koppel et al., 2004), we
evaluated the role of SIGNR1 by establishing SIGNR1-deficient406 Immunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc.mice (Figure S4A). However, BMDCs
lacking SIGNR1 were still capable of pro-
ducing all cytokines tested at amounts
comparable to those in WT BMDCs (Fig-
ure S4B). Another DC-SIGN homolog,
SIGNR3, which is expressed in a limited
population of myeloid cells (Nagaoka
et al., 2010), was not detected in BMDCs
(Figure S4C). Furthermore, forced
expression of SIGNR3 in BMDCs did not
increase Man-LAM-induced cytokine
production (Figure S4D). Notably,
Clec4n/ BMDCs failed to produce cy-
tokines even with the expression of
SIGNR3 (Figure S4D). These results
collectively indicate that both SIGNR1
and SIGNR3 are not essential for cytokine
production induced by Man-LAM in
BMDCs.
Macrophage mannose receptor (MMR)
could also bind to Man-LAM (Nigou et al.,
2001). Because MMR expression was
detected in BMDCs (Figure S4C), we as-
sessed its role in Man-LAM-induced
cytokine release by using anti-MMR
blocking monoclonal antibody (mAb).
However, themAb treatment did not influ-
ence the production of IL-10 and IL-2 in
BMDCs (Figure S4E).
A recent report has shown that Dectin-
2 is capable of associating with MCL (Zhuet al., 2013). Meanwhile, analyses ofClec4d/BMDCs revealed
that MCL is not required for the Man-LAM-induced cytokine pro-
duction (Figure S4F). Man-LAM is weakly recognized by TLR2
and TLR4 (Mazurek et al., 2012). However, IL-10 production
induced by Man-LAMwas not altered inMyD88/ BMDCs (Fig-
ure S4G), suggesting that TLR-MyD88 signaling does not play a
major role in the effect of Man-LAM. Finally, we confirmed that
the direct engagement of Dectin-2 alone by anti-Dectin-2 cross-
linking replicated the production of IL-10 (Figure S4H).
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D
B Figure 5. LAM Does Not Cause Excessive
Inflammation in the Lungs
(A and B) Mice were intratracheally administered
100 mg of LAM (WT, n = 13; Fcer1g–/–, n = 5), 10 mg
of LPS (WT, n = 9), or 100 ml of sterile saline as a
control (WT, n = 7). After 8 hr, BALF was obtained
and then TNF concentrations in the BALF were
determined using ELISA (A). The number of total
cells was determined by hemocytometer (B). All
data are presented as the means ± SD.
(C) Lungs of control mice (Cont., n = 11), 50 mg of
LAM (LAM, n = 11)- or 50 mg of TDM (TDM, n = 7)-
injected mice were isolated at day 7 and inflam-
matory intensity was evaluated by calculation of
lung weight index. Each symbol represents an in-
dividual mouse. Data are representative of three
separate experiments.
(D) Histology of the lungs from control, LAM
(50 mg)-, or TDM (50 mg)-injected mice were was
examined by hematoxylin-eosin staining at day 7.
Scale bars represent 0.1 mm. Data are represen-
tative of three separate experiments.
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tential of Man-LAM is likely due to the intrinsic properties of Dec-
tin-2-mediated signaling.
Man-LAM Induces Minimal Inflammation In Vivo
To investigate whether Man-LAM triggers any inflammatory
responses, we evaluated the response of mice to Man-LAM
administration in vivo. The infiltration of inflammatory cells and
cytokine production in bronchoalveolar lavage fluid (BALF) was
examined following the intratracheal administration of LAM or
LPS (Figures 5A and 5B). LPS induced a significant increase in
TNF production and cell infiltration in WT mice. In contrast,
Man-LAM did not induce marked inflammatory responses.
Consistent with this observation, FcRg deficiency had no
apparent effect compared with Man-LAM-treated WT mice.
Intravenous injection of TDM induced inflammatory lung
swelling as assessed by lung weight index (LWI) (Figure 5C)
and granuloma formation in lungs (Figure 5D, right) as previously
reported (Ishikawa et al., 2009). In contrast, the same amount of
Man-LAM induced neither lung swelling (Figure 5C) nor granu-
loma formation (Figure 5D, middle). These results indicate that
Man-LAM does not induce strong pulmonary inflammation
compared with other PAMPs such as TDM or LPS.Immunity 41, 402–413, SeMan-LAM Stimulation Enhances
APC Functions to Promote IL-17
Production In Vitro
We further evaluated the adjuvant activity
of Man-LAM in vitro. To investigate the ef-
fect of Man-LAM on DC maturation, we
examined the expression of costimula-
tory molecules on BMDCs after Man-
LAM stimulation. Man-LAM stimulation
upregulated the expression of CD40 and
CD80 on WT BMDCs, which were com-
parable to those induced by LPS (Fig-
ure 6A). However, the induction of these
costimulatory molecules was abolishedin the absence of Dectin-2 and its subunit FcRg (Figure 6A).
Mincle was dispensable for the LAM-induced responses. We
confirmed that the LPS-mediated responses were not altered
in these mice. These results demonstrate that Man-LAM pro-
motes DC maturation in a Dectin-2-dependent manner.
We next examined the function of antigen-presenting cells
(APCs) upon Man-LAM stimulation. BMDCs were pulsed with
the ovalbumin (OVA) antigen peptides and cocultured with
T cells obtained from OVA-specific OT-II TCR transgenic mice
in the presence or absence of Man-LAM. Because T cells do
not express Dectin-2 (Ariizumi et al., 2000), this system enables
us to evaluate the role of Man-LAM in APC functions toward
T cell priming and activation. The antigen-specific secretion of
IL-17 from CD4+ OT-II T cells was significantly augmented
when the cells were cocultured with Man-LAM-treated APCs
(Figure 6B). However, this enhancement was markedly attenu-
ated when Clec4n/ APCs were used. The antigen-induced
T cell proliferation, as assessed by CFSE dilution, was observed
regardless of Dectin-2 expression on DCs (Figure 6B, bottom).
The concentration of IL-10 in coculture supernatant was
increased depending on the antigen dose, suggesting the gener-
ation of IL-10-producing T cells in the presence of DCs stimu-
lated through Man-LAM-Dectin-2 axis (Figure 6B).ptember 18, 2014 ª2014 Elsevier Inc. 407
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Figure 6. LAM Induces Acquired Immune
Responses through Dectin-2
(A) BMDCs obtained from WT, Clec4n–/–,
Clec4e–/–, or Fcer1g–/– mice were left untreated or
stimulated with plate-coated LAM or LPS for 48 hr.
The surface expressions of CD40 and CD80 were
analyzed using flow cytometry.
(B) BMDCs were pulsed with OVA323-339 peptides
and cocultured with CFSE-labeled CD4+ OT-II
T cells for 3 days in the presence or absence of
plate-coated LAM. Cytokine concentrations were
determined using ELISA. Cell proliferation was
analyzed using flow cytometry for dilution of CFSE
within the CD4+ population. The data are pre-
sented as the means ± SD of triplicate and are
representative of three separate experiments.
(C and D) WT (n = 10) and Clec4n–/– (n = 10) mice
were immunized with MOG35-55 peptide in IFA
containing LAM (500 mg) as described in Figure 1A.
Mean clinical score (C) and disease incidence (D)
at the indicated times were plotted.
(E) Lymph nodes were collected at 23 days
after immunization for EAE and stimulated with
MOG35-55 peptide for 4 days. Cytokine concen-
trations were determined using ELISA. The data
are presented as the means ± SD.
See also Figure S5.
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coculture even in the absence of antigen, which also required
Dectin-2 on DCs (Figure 6B). This ‘‘antigen-independent
proliferation’’ might be conferred by a large amount of IL-2
secretion through Dectin-2 on DCs (Figure 4C), because the
addition of anti-IL-2 neutralizing mAb ablated this response
(Figure S5A).
In contrast to the enhancement of IL-17 production, Man-LAM
treatment had essentially no effect on the antigen-dependent
IFN-g production (Figure 6B). IL-4 was not detected at any
time point in this experiment (data not shown). Collectively, these
in vitro results suggest that Man-LAM stimulation enhances APC408 Immunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc.functions to promote IL-17 production in
a Dectin-2-dependent manner.
Man-LAM Promotes Antigen-
Specific Human T Cell Responses
through Human Dectin-2
We then assessed whether Man-LAM
influences human T cell responses as
observed in murine T cells. Importantly,
Man-LAM activated reporter cells ex-
pressing hDectin-2, and this activity was
blocked in the presence of anti-hDectin-
2 mAb (Figure S5B). The Man-LAM-
induced cytokine production in human
monocytes and monocyte-derived DCs
was also significantly suppressed by
anti-hDectin-2 mAb (Figures S5C and
S5D). Peripheral blood mononuclear
cells (PBMCs) from tuberculosis patients
were stimulated with C10 peptide(VVRFQEAANKQKQEL) of CFP-10 (10 kDa culture filtrate anti-
gen) from M. tuberculosis. Antigen peptides alone induced a
substantial amount of IFN-g production in PBMCs, whereas it
was augmented upon Man-LAM stimulation in combination
with antigen peptides. Man-LAM-induced augmentation of
IFN-g production was markedly compromised in the presence
of anti-hDectin-2 mAb (Figure S5E). The Dectin-2-dependent
enhancement of IFN-g production was also observed in three
other individuals (Figure S5F). These results indicate that Man-
LAM-hDectin-2 interaction promotes the mycobacterial anti-
gen-specific responses of T cells from tuberculosis patients,
presumably through the activation of myeloid cells in PBMCs.
AB
C
Figure 7. Immune Responses against
Mycobacterial Infection in Clec4n–/– Mice
(A) Higher lung weights in Clec4n–/– mice. Lungs
were isolated 23 days after infection of MAC. WT
(n = 10) and Clec4n–/– (n = 10) mice were used.
(B) Histological analysis of the lung from unin-
fected- or MAC-infected WT or Clec4n–/– mice by
HE staining. Scale bars represent 0.1 mm.
(C) Cytokine production in splenocytes after re-
stimulation with sensitin or MACAg85 for 4 days.
Splenocytes were obtained 23 days after infection
of MAC and pooled from ten mice in each group.
The data are presented as mean ± SD.
See also Figure S6.
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Dectin-2 Is a Receptor for Mycobacterial Man-LAMInduction of EAE through Man-LAM Immunization via
Dectin-2-FcRg Axis
We next performed a murine model of T helper 17 (Th17) cell-
mediated autoimmune disease, EAE, since Dectin-2 activation
by Man-LAM induced IL-17 production in vitro (Figure 6B).
Strikingly, Clec4n–/– mice were completely resistant to Man-
LAM-induced EAE (Figures 6C and 6D), indicating that other
Man-LAM receptors cannot compensate for the loss of Dectin-
2 in vivo. Furthermore, ex vivo recall responses, as assessed
by the production of IL-17, IFN-g, and GM-CSF, of the lymph
node cells collected from inguinal, lumbar, and axillary lymph no-
des were completely abrogated in Clec4n–/– mice (Figure 6E).
This indicates that Man-LAM cannot efficiently prime T cells in
Dectin-2-deficient environment. Taken together, Dectin-2 is a re-
ceptor essential for the adjuvanticity of Man-LAM in vivo.Immunity 41, 402–413, SeRole of Dectin-2 in Mycobacterial
Infection
Finally, we examined the role of Dectin-2
in mycobacterial infection in vivo. WT
and Clec4n/ mice were infected in-
tranasally with M. avium complex (MAC).
Although the bacterial burden in the lungs
was not significantly altered at 3 weeks
after infection, the average number of col-
ony forming units (CFU) per lungs was
larger in Clec4n–/– mice than in WT mice
(WT, 6.54 ± 6.47; Clec4n–/–, 13.1 ± 8.32
[3 102]). We therefore characterized the
lung pathology of infected mice. Lung
swelling as assessed from lung mass
was significantly greater in Clec4n–/–
mice (Figure 7A). In addition, Clec4n–/–
mice presented with increased histopa-
thology in the lungs after infection (Fig-
ure 7B). Chemokine concentrations were
elevated in the lungs of Clec4n–/– mice
compared with WT mice 3 weeks after
infection (Figure S6). These chemokines
seemed to be inducedbybacteria residing
in the lungs, because the chemokine con-
centration in each individual mouse was
correlated with the bacterial burden in
the lungs (data not shown). The produc-
tion of cytokines, such as TNF, IL-6, andIL-10, were not elevated in the lungs of WT and Clec4n–/– mice
at day 23 after infection (data not shown). We also examined an-
tigen-specific T cell responses in the infectedmice. Splenic T cells
from Clec4n/ mice produced a significantly larger amount of
IFN-g upon recall stimulation bymycobacterial antigens, whereas
IL-17 production was not altered (Figure 7C). Thus, Dectin-2 defi-
ciency resulted in augmented lung pathology and acquired immu-
nity presumably due to the inefficient elimination ofmycobacteria.
Collectively, these results suggest that Dectin-2 is involved in host
defense against mycobacteria.
DISCUSSION
In this manuscript, we have demonstrated that Dectin-2 is a
direct and functional receptor for mycobacterial Man-LAM.ptember 18, 2014 ª2014 Elsevier Inc. 409
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Dectin-2 Is a Receptor for Mycobacterial Man-LAMMincle, MCL, and Dectin-2 are located in the same gene cluster,
and we found that all these CLRs recognize mycobacteria (Ishi-
kawa et al., 2009;Miyake et al., 2013). The acquisition of different
CLRs recognizing distinct mycobacterial components during
evolution would enable the host to exert stable immune re-
sponses against this life-threatening bacteria.
Dectin-2 has been reported to recognize high-mannose struc-
tures of fungi (McGreal et al., 2006), such as a-1,2-mannan
derived from Candida albicans (Robinson et al., 2009; Saijo
et al., 2010) andmannoprotein fromMalassezia fungus (Ishikawa
et al., 2013). Glycan array analysis confirms that Dectin-2 prefer-
entially binds to high-mannose structures, similar to DC-SIGN,
SIGNR1, SIGNR3, and MMR (McGreal et al., 2006), all of which
possess themannose-binding EPN sequence within their carbo-
hydrate recognition domains (CRDs) (Drickamer, 1992). Man-
LAM possesses polysaccharide chains that terminates in a
a-1,2-mannose cap (Mishra et al., 2011). It is highly likely that
the a-1,2-linked mannose residues of Man-LAM are the direct
determinant recognized by Dectin-2.
Man-LAM is densely distributed in the envelopes of mycobac-
teria with the specific configuration, and thereby their polar
mannose caps are exposed on the bacterial surface with oligo-
meric valency. The multivalent a-1,2-mannose residue is not
inconsistent with the characteristics of PAMPs recognized by
Dectin-2 (Ishikawa et al., 2013; Saijo et al., 2010). To replicate
this configuration in vitro, Man-LAM was used as plate-coated
form to evaluate Dectin-2-mediated responses in this study. Pre-
vious studies show that soluble Man-LAM alone does not induce
cytokine production in myeloid cells (Geijtenbeek et al., 2003;
Gringhuis et al., 2009; Nigou et al., 2001) and we confirmed
this with BMDCs (data not shown). These different outcomes
depending on the stimuli might be attributed to the difference
in the receptor engagement caused by the nature of the
ligand—monovalent (soluble) versus multivalent (immobilized).
It has been demonstrated that soluble Man-LAM influences
myeloid cell function in the presence of other stimuli such as
TLR ligands (Geijtenbeek et al., 2003; Gringhuis et al., 2007; Ni-
gou et al., 2001). One possible explanation for these findings is
that TLR-bound lipoprotein might provide a scaffold for soluble
Man-LAM through hydrophilic interaction in aqueous media,
which leads to ligand multimerization sufficient for the engage-
ment of Dectin-2. Consistent with these ideas, multimerized
Man-LAM in oil emulsion exhibited potent adjuvant activity
in vivo. Collectively, Dectin-2 might discriminate multivalent
PAMPs presented on ‘‘real’’ pathogens, presumably to prevent
false recognition of their targets.
The a-1,2-linked mannose residues are also present in phos-
phatidyl-myo-inositol mannosides (PIMs). Because PIMs have
been shown to be potentially associated with MMR and DC-
SIGN (Torrelles et al., 2006), Dectin-2 might recognize PIMs.
However, M. abscessus, which lacks Man-LAM but possesses
PIMs, did not activate reporter cells expressing Dectin-2,
implying that PIMs might not be a potent ligand for Dectin-2.
Alternatively, Dectin-2 may not be able to access ‘‘short’’ PIMs
within ‘‘tall’’ cell wall components, such as long-chain mycolic
acids, glycolipids, lipoglycans, and polysaccharides (Mishra
et al., 2011; Torrelles et al., 2006).
SIGNR1, SIGNR3, andMMRhave been reported asmurine re-
ceptors for Man-LAM (Koppel et al., 2004; Schlesinger et al.,410 Immunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc.1994; Tanne et al., 2009). Peritoneal macrophages from
Cd209b–/– mice produce less, but detectable, IL-10 in response
to Man-LAM (Wieland et al., 2007). However, gene ablation of
SIGNR1 and anti-MMR blocking mAb did not influence the
LAM-induced cytokine production in BMDCs. SIGNR3 is not ex-
pressed on BMDCs and forced expression of SIGNR3 did not
rescue cytokine production inClec4n–/– BMDCs. Thus, the char-
acteristic cytokine production induced byMan-LAM seems to be
determined by intrinsic signaling via Dectin-2 in DCs. Although
Man-LAM-induced in vivo responses were also completely abol-
ished in Clec4n–/– mice, it is possible that SIGNR3 plays a role
in Man-LAM responses in particular cells, such as dermal DCs,
that express SIGNR3 (Nagaoka et al., 2010). Alternatively,
these Man-LAM-binding molecules might promote the binding
of myeloid cells to Man-LAM-bearing bacteria (Tanne et al.,
2009), thereby leading to the efficient phagocytosis of
mycobacteria.
Our data demonstrate that Man-LAM is a sufficient compo-
nent to trigger IL-10 production. However, we cannot exclude
the possibility that Man-LAM is not necessarily required for
IL-10 production induced by whole mycobacteria, although
NTM strain M. abscessus lacking Man-LAM did not induce
IL-10 production. The results from mutant M. bovis BCG, which
lacks the mannose cap of LAM, suggest its redundant role in
IL-10 production in LPS-primed human DCs (Appelmelk et al.,
2008). It has been reported that mycobacteria may possess
other possible unidentified Dectin-2 ligands, such as mannosy-
lated proteins (Pitarque et al., 2005). These components might
account, at least in part, for the IL-10 production induced by
whole bacteria.
It has been reported that the IL-10 production during infection
correlates with susceptibility to M. tuberculosis. Large amounts
of IL-10 can be detected in the serum of active tuberculosis
patients, particularly in response to hypervirulent strains of
M. tuberculosis (O’Garra et al., 2013). In line with these observa-
tions, increased susceptibility to mycobacteria has been shown
in mice that constitutively overexpressed IL-10 (Feng et al.,
2002). In addition, secretion of another immune-regulatory cyto-
kine transforming growth factor-b (TGF-b) was also slightly
enhanced by Man-LAM through Dectin-2 (data not shown).
However, the precise contribution of the mannose cap of LAM
to the virulency ofmycobacteria still remains controversial in vivo
(Afonso-Barroso et al., 2012; Appelmelk et al., 2008).
On the other hand, it has been proposed that IL-10 might limit
excessive damage to the host tissue (Redford et al., 2011). The
mutant mice lacking CARD9, a downstream adaptor of FcRg,
exhibited severe lung pathology and enhanced lethality in
response to M. tuberculosis, which is correlated with abolished
secretion of IL-10 (Dorhoi et al., 2010). Although CARD9 alsome-
diates signaling through Mincle, the effect of Mincle deficiency
on the pathologies during mycobacterial infection was modest
compared with those ofCARD9–/– mice (Behler et al., 2012; Heit-
mann et al., 2013; Lee et al., 2012). Given the augmented lung
inflammation in Clec4n–/– mice, the Dectin-2-FcRg-CARD9 axis
appears to be involved in the control of mycobacterial infection.
Indeed, Fcer1g–/– mice showed increased immunopathology in
the lungs during mycobacterial infection (Maglione et al., 2008).
How does Man-LAM efficiently promote Th17 cell responses
in mice? A previous study demonstrates that Dectin-2 ligand is
Immunity
Dectin-2 Is a Receptor for Mycobacterial Man-LAMcapable of inducing the Th17 cell differentiation through the
release of soluble factors (Saijo et al., 2010). Man-LAM stimu-
lation also induced the production of IL-6, TNF, and TGF-b, all
of which are Th17-cell-inducing cytokines. In addition, we
observed that the transcription of IL-23p19 was upregulated in
BMDCs upon Man-LAM in a Dectin-2-dependent fashion (data
not shown), as previously reported in BMDCs stimulated with
C. albicans (Robinson et al., 2009). A recent report has demon-
strated that a NTM strain M. avium bearing Man-LAM could
induce IL-23 production. This activity is lost in the lipophilic
extract of the strain (Jo¨nsson et al., 2012), supporting the idea
that hydrophilic Man-LAM is involved in the promotion of Th17
cell differentiation.
In human PBMCs from tuberculosis patients, we found that
Man-LAM enhanced IFN-g production induced by mycobacte-
rial antigen. The undetectable concentration of IL-17 secretion
(data not shown) is consistent with previous observation (Yama-
shita et al., 2013), although the underlying mechanism is
currently unknown. One possible explanation is that T cells in
tuberculosis patients might have already skewed to a Th1 cell
phenotype upon repetitive antigen exposure during infection.
In sharp contrast to Mincle ligand TDM, Dectin-2 ligand Man-
LAM uniquely induces the production of IL-10 and IL-2, despite
the fact that both CLRs share the same signaling subunit FcRg.
IL-2 production fromDCsmight contribute to the adjuvanticity by
promoting T cell priming (Granucci et al., 2001). Previous studies
have highlighted the role of Syk-CARD9 pathway in the produc-
tion of IL-10 and IL-2 in DCs (LeibundGut-Landmann et al., 2007;
Robinson et al., 2009; Saijo et al., 2010), because the TLR-
MyD88 or TRIF pathway does not lead to secretion of these
cytokines (LeibundGut-Landmann et al., 2007). However, the
Syk-CARD9 pathway is not sufficient to induce these cytokines,
because the Mincle ligand TDM did not allow the production of
either IL-10 or IL-2. It remains unclear how distinct CLRs lead
to different cellular responses through a common signaling sub-
unit. We previously reported that the quantity and duration of
FcRg signals can determine the quality of cellular responses (Ya-
masaki et al., 2004). It is intriguing to hypothesize that the ki-
netics, affinity, or valency of receptor engagement potentially
generates distinct signaling through FcRg.
In addition to the functions of Man-LAM described above,
Man-LAM is known to have pleiotropic functions during myco-
bacterial infection. Mycobacteria limit phagosome-lysosome
fusion to survive in macrophages, which allow mycobacteria to
establish latent and persistent infection (Pieters, 2008). Man-
LAM is one of the candidate involved in this process (Fratti
et al., 2003; Vergne et al., 2004), although more detailed studies
are needed to determine whether Dectin-2-mediated signaling
affects phagosome-lysosome fusion. A recent study has demon-
strated that Man-LAM treatment inhibits T cell migration from the
draining lymph nodes (Richmond et al., 2012). This effect seems
to occur independently of Dectin-2, as its expression was not de-
tected in any subsets of T cells (Ariizumi et al., 2000).
In the present study, we have shown that Dectin-2 recognizes
Man-LAM to mediate its adjuvanticity. In addition, the simulta-
neous induction of both immunostimulatory and inhibitory re-
sponses by Man-LAM-Dectin-2 axis might be beneficial for
host organisms tomaintain balanced immune responses. During
EAE development, skin inflammation is observed at the injectionImsite when TDM was used as an adjuvant (Miyake et al., 2013).
However, no such inflammation was observed in the skin of
Man-LAM-injected mice (data not shown), implying that the
anti-inflammatory cytokines induced by Man-LAM might control
excessive inflammation at the injection site. The limited inflam-
matory responses induced byMan-LAM could thus be beneficial
as an adjuvant for therapeutic vaccines for infectious diseases
and cancer. It is therefore proposed that Man-LAM analogs
might represent unique hydrophilic ‘‘regulatory’’ adjuvants that
promote the development of acquired immunity, with minimal
detrimental inflammation.
EXPERIMENTAL PROCEDURES
Lipids Extract
M. bovis BCG was fractionated by distilled water with repeated washing five
times. After centrifugation, the soluble fraction was collected. The insoluble
fraction was further delipidated with C:M (2:1, vol/vol). Each fraction was re-
suspended in a volume of isopropanol at equivalent amount of 0.1 mg as the
original M. bovis BCG weight.
Cells
2B4-NFAT-GFP reporter cells expressing FcRg alone, Mincle, Dectin-2, and
Dectin-2QPD were prepared as previously described (Yamasaki et al., 2009).
BMDCs were prepared as previously described (Miyake et al., 2013).
In Vitro Stimulation
Mycobacterial lipid extracts, LAM in aqueous solution (1 mg/ml), TDM dis-
solved in C:M at 1 mg/ml, and Candida albicans cell wall mannan (5 mg/ml)
were diluted in isopropanol and added to 96-well plates at 20 ml/well, followed
by evaporation of the solvents as previously described (Ishikawa et al., 2009).
Reporter cells were stimulated for 24 hr and the activation of NFAT-GFP was
monitored using flow cytometry. BMDCs were stimulated for 2 days, then the
culture supernatants were collected. The concentrations of each cytokine
were determined by ELISA. Activation was determined using surface staining
of the costimulatory molecules CD40 and CD80 by flow cytometry.
OVA-Specific CD4+ T Cell Responses
BMDCs were generated from WT and Clec4n/ mice as described above.
BMDCs were left untreated or stimulated with indicated amount of plate-
coated LAM in the presence of OVA323-339 peptides (ABGENT). CD4
+ T cells
from OT-II Tg mice were purified with anti-CD4-conjugated magnetic beads
(MACS, Miltenyi) and then labeled with CFSE (DOJINDO) and cocultured
with OVA-pulsed DCs in 96-well plates. On day 3, the supernatants were har-
vested and determined the concentration of IFN-g, IL-17, and IL-10 using
ELISA. CFSE-labeled T cells were analyzed for dilution of CFSE within the
CD4+ T cell population using flow cytometry.
Experimental Autoimmune Encephalomyelitis
Mice were immunized via subcutaneous administration of 200 mg of MOG35-55
peptide (Invitrogen) emulsified in IFA (Difco) containing 500 mg of LAM on day
0. The mice received three daily intraperitoneal (i.p.) administrations of 500 ng
of pertussis toxin (PT) (List Biological Laboratories) starting on day 1. The
disease severity was scored as previously described (Miyake et al., 2013).
For the in vitro restimulation analysis, cells were collected from the axillary,
inguinal, and lumbar (paraaortic) lymph nodes on day 23. Lymphocytes
(5 3 105 cells/well) were stimulated with MOG35-55 peptides at the indicated
concentrations for 4 days. The concentrations of IL-17, IFN-g, and GM-SCF
in culture supernatants were determined by ELISA. All animal protocols were
approved by the committee of Ethics on Animal Experiment, Faculty of Med-
ical Sciences, Kyushu University, Chiba University, or Tokyo University of
Pharmacy and Life Sciences.
Mycobacterial Infection
For in vitro infection, BMDCs were infected with 1 to 103 109 CFU ofM. bovis
BCG. After 48 hr, the culture supernatants were collected and cytokinemunity 41, 402–413, September 18, 2014 ª2014 Elsevier Inc. 411
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Dectin-2 Is a Receptor for Mycobacterial Man-LAMconcentration was determined by ELISA. For in vivo infection, WT mice and
Clec4n/ mice were anesthetized with isoflurane, and each mouse was sub-
sequently infected intranasally with 2.5 3 106 CFU M. avium complex (MAC)
per mouse. At 3 weeks after infection, the lungs were isolated and homoge-
nized with a Physcotron handy microhomogenizer (Microtec). Serial dilutions
of the homogenates were subjected to the determination of CFU on 7H11
agar plates supplemented with OADC and penicillin (100 U/ml). The homoge-
nateswere also subjected to the determination of chemokines with a Cytomet-
ric Bead Array System (BD Biosciences). Lungs from other infected mice were
fixed with 10% formaldehyde for hematoxylin-eosin staining. Single-cell sus-
pensions of splenocytes (53 105 cells) were stimulated withM. avium sensitin
PPD (5 mg/ml) or MAC Ag85A (10 mg/ml) for 4 days, and the concentrations of
cytokines and chemokines in culture supernatants were determined by ELISA.
Four patients of National Tokyo Hospital in Tokyo, Japan, were enrolled in this
study after giving informed consent. The research protocol was approved by
the Institutional Review Board of National Tokyo Hospital and by the ethical
committee of the National Institute of Infectious Diseases for medical research
using human subjects.SUPPLEMENTAL INFORMATION
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